|
1.
|
Samson T, Smyth N, Janetzky S, Wendler O,
Müller JM, Schüle R, von der Mark H, von der Mark K and Wixler V:
The LIM-only proteins FHL2 and FHL3 interact with alpha- and
beta-subunits of the muscle alpha7beta1 integrin receptor. J Biol
Chem. 279:28641–28652. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Labalette C, Nouet Y, Sobczak-Thepot J,
Armengol C, Levillayer F, Gendron MC, Renard CA, Regnault B, Chen
J, Buendia MA and Wei Y: The LIM-only protein FHL2 regulates cyclin
D1 expression and cell proliferation. J Biol Chem. 283:15201–15208.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Chan KK, Tsui SK, Lee SM, Luk SC, Liew CC,
Fung KP, Waye MM and Lee CY: Molecular cloning and characterization
of FHL2, a novel LIM domain protein preferentially expressed in
human heart. Gene. 210:345–350. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Sanchez-Garcia I, Osada H, Forster A and
Rabbitts TH: The cysteine-rich LIM domains inhibit DNA binding by
the associated homeodomain in Isl-1. EMBO J. 12:4243–4250.
1993.PubMed/NCBI
|
|
5.
|
Bach I: The LIM domain: regulation by
association. Mech Dev. 91:5–17. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Johannessen M, Moller S, Hansen T, Moens U
and Van Ghelue M: The multifunctional roles of the
four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci.
63:268–284. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Morlon PA and Sassone-Corsi P: The
LIM-only protein FHL2 is a serum inducible transcriptional
coactivator of AP-1. Proc Natl Acad Sci USA. 100:3977–3982. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Fimia GM, Cesare DDe and Sassone-Corsi P:
A family of LIM-only transcriptional coactivators: tissue-specific
expression and selective activation of CREB and CREM. Mol Cell
Biol. 20:8613–8622. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Yan J, Zhu J, Zhong H, Lu Q, Huang C and
Ye Q: BRCA1 interacts with FHL2 and enhances FHL2 transactivation
function. FEBS Lett. 553:183–189. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Du X, Hublitz P, Günther T, Wilhelm D,
Englert C and Schüle R: The LIM-only coactivator FHL2 modulates WT1
transcriptional activity during gonadal differentiation. Biochim
Biophys Acta. 1577:93–101. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Stilo R, Leonardi A, Formisano L, Jeso B
Di, Vito P and Liguoro D: TUCAN/CARDINAL and DRAL participate in a
common pathway for modulation of NF-kappaB activation. FEBS Lett.
521:165–169. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Purcell NH, Darwis D, Bueno OF, Müller JM,
Schüle R and Molkentin JD: Extracellular signal-regulated kinase 2
interacts with and is negatively regulated by the LIM-only protein
FHL2 in cardiomyocytes. Mol Cell Biol. 24:1081–1095. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
McLoughlin P, Ehler E, Carlile G, Licht JD
and Schafer BW: The LIM only protein DRAL/FHL2 interacts with and
is a corepressor for the promyelocytic leukemia zinc finger
protein. J Biol Chem. 277:37045–37053. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Philippar U, Schratt G, Dieterich C,
Müller JM, Galgóczy P, Engel FB, Keating MT, Gertler F, Schüle R,
Vingron M and Nordheim A: The SRF target gene Fhl2 antagonizes
RhoA/MAL-dependent activation of SRF. Mol Cell. 16:867–880. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yang Y, Hou H, Haller EM, Nicosia SV and
Bai W: Suppression of FOXO1 activity by FHL2 through SIRT1-mediated
deacetylation. EMBO J. 24:1021–1032. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Genini M, Schwalbe P, Scholl FA, Remppis
A, Mattei MG and Schafer BW: Subtractive cloning and
characterization of DRAL, a novel LIM-domain protein down-regulated
in rhabdomyosarcoma. DNA Cell Biol. 16:433–442. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Martin BT, Kleiber K, Wixler V, Raab M,
Zimmer B, Kaufmann M and Strebhardt K: FHL2 regulates cell
cycle-dependent and doxorubicininduced p21Cip1/Waf1 expression in
breast cancer cells. Cell Cycle. 6:1779–1788. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kinoshita M, Nakagawa T, Shimizu A and
Katsuoka Y: Differently regulated androgen receptor transcriptional
complex in prostate cancer compared with normal prostate. Int J
Urol. 12:390–397. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Wang J, Yang Y, Xia HH, Gu Q, Lin MC,
Jiang B, Peng Y, Li G, An X, Zhang Y, Zhuang Z, Zhang Z, Kung HF
and Wong BC: Suppression of FHL2 expression induces cell
differentiation and inhibits gastric and colon carcinogenesis.
Gastroenterology. 132:1066–1076. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Li M, Wang J, Ng SS, Chan CY, Chen AC, Xia
HP, Yew DT, Wong BC, Chen Z, Kung HF and Lin MC: The
four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas
and associated with oncogenic activities. Glia. 56:1328–1338. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Ding L, Wang Z, Yan J, Yang X, Liu A, Qiu
W, Zhu J, Han J, Zhang H, Lin J, Cheng L, Qin X, Niu C, Yuan B,
Wang X, Zhu C, Zhou Y, Li J, Song H, Huang C and Ye Q: Human
four-and-a-half LIM family members suppress tumor cell growth
through a TGFbeta-like signaling pathway. J Clin Invest.
119:349–361. 2009.PubMed/NCBI
|
|
22.
|
Scholl FA, McLoughlin P, Ehler E, de
Giovanni C and Schafer BW: DRAL is a p53-responsive gene whose four
and a half LIM domain protein product induces apoptosis. J Cell
Biol. 151:495–506. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Amann T, Egle Y, Bosserhoff AK and
Hellerbrand C: FHL2 suppresses growth and differentiation of the
colon cancer cell line HT-29. Oncol Rep. 23:1669–1674.
2010.PubMed/NCBI
|
|
24.
|
Zhang W, Jiang B, Guo Z, Sardet C, Zou B,
Lam CS, Li J, He M, Lan HY, Pang R, Hung IF, Tan VP, Wang J and
Wong BC: Four and a half LIM protein 2 (FHL2) promotes invasive
potential and epithelial-mesenchymal transition in colon cancer.
Carcinogenesis. 31:1220–1229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Zhang W, Wang J, Zou B, Sardet C, Li J,
Lam CS, Ng L, Pang R, Hung IF, Tan VP, Jiang B and Wong BC: Four
and a half LIM protein 2 (FHL2) negatively regulates the
transcription of E-cadherin through interaction with Snail1. Eur J
Cancer. 47:121–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Takada M, Nakamura Y, Koizumi T, Toyama H,
Kamigaki T, Suzuki Y, Takeyama Y and Kuroda Y: Suppression of human
pancreatic carcinoma cell growth and invasion by
epigallocatechin-3-gallate. Pancreas. 25:45–48. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Ewald JA, Desotelle JA, Church DR, Yang B,
Huang W, Laurila TA and Jarrard DF: Androgen deprivation induces
senescence characteristics in prostate cancer cells in vitro and in
vivo. Prostatex. 73:337–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Kar S, Palit S, Ball WB and Das PK:
Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces
intrinsic and extrinsic pathway mediated apoptosis in human
prostate carcinoma PC-3 cells. Apoptosis. 7:35–47. 2012.PubMed/NCBI
|
|
29.
|
Chao TC and Greager JA: Experimental
pulmonary sarcoma metastases in athymic nude mice. J Surg Oncol.
65:123–126. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Wendtner CM, Kofler DM, Theiss HD,
Kurzeder C, Buhmann R, Schweighofer C, Perabo L, Danhauser-Riedl S,
Baumert J, Hiddemann W, Hallek M and Büning H: Efficient gene
transfer of CD40 ligand into primary B-CLL cells using recombinant
adeno-associated virus (rAAV) vectors. Blood. 100:1655–1661.
2002.PubMed/NCBI
|
|
31.
|
Chatfield K and Eastman A: Inhibitors of
protein phosphatases 1 and 2A differentially prevent intrinsic and
extrinsic apoptosis pathways. Biochem Biophys Res Commun.
323:1313–1320. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Mühlethaler-Mottet A, Bourloud KB,
Auderset K, Joseph JM and Gross N: Drug-mediated sensitization to
TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma
cells proceeds via activation of intrinsic and extrinsic pathways
and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. Oncogene.
23:5415–5425. 2004.
|
|
33.
|
Obexer P, Geiger K, Ambros PF, Meister B
and Ausserlechner MJ: FKHRL1-mediated expression of Noxa and Bim
induces apoptosis via the mitochondria in neuroblastoma cells. Cell
Death Differ. 14:534–547. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Guo XL, Li D, Hu F, Song JR, Zhang SS,
Deng WJ, Sun K, Zhao QD, Xie XQ, Song YJ, Wu MC and Wei LX:
Targeting autophagy potentiates chemotherapy-induced apoptosis and
proliferation inhibition in hepatocarcinoma cells. Cancer Lett.
320:171–179. 2012. View Article : Google Scholar
|
